Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis

Journal of Infectious Diseases

Volumn 195, Issue 1, 2007, Pages 70-80

  Hogardt, Michael ^a   Hoboth, Christina ^a   Schmoldt, Sabine ^a   Henke, Christine ^a   Bader, Lutz ^a   Heesemann, Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; FOSFOMYCIN; MEROPENEM; POLYMYXIN; RIFAMPICIN; TOBRAMYCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BASE MISPAIRING; CELL SURVIVAL; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOTOXICITY; DETERIORATION; DNA REPAIR; EPITHELIUM CELL; GENE ISOLATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATION RATE; MUTS GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 33845623880     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/509821     Document Type: Article

References (32)

1. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15:194-222.
2. Baltimore RS, Christie CD, Smith GJ. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis: implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989; 140:1650-61.
3. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4:35-51.
4. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000; 288:1251-4.
5. Ciofu O, Riis B, Pressler T, Poulsen HE, Hoiby N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 2005; 49:2276-82.
6. Watson ME Jr, Burns JL, Smith AL. Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 2004; 150:2947-58.
7. Prunier A-L, Malbruny B, Laurans M, Brouard J, Duhamel J-F, Leclercq R. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 2003; 187:1709-16.
8. Oliver A, Baquero F, Blazquez J. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 2002; 43: 1641-50.
9. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 2005; 49:3382-6.
10. Hogardt M, Schubert S, Adler K, Gotzfried M, Heeseman J. Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates. Int J Med Microbiol 2006; 296:313-20.
11. Hogardt M, Trebesius K, Geiger AM, Hornef M, Rosenecker J, Heesemann J. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol 2000; 38:818-25.
12. Romling U, Fiedler B, Bosshammer J, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994; 170:1616-21.
13. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 1996; 34:1129-35.
14. Andrews JM, BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 5). J Antimicrob Chemother 2006; 58:511-29.
15. Kiratisin P, Tucker KD, Passador L. LasR, a transcriptional activator of Pseudomonas aeruginosa virulence genes, functions as a multimer. J Bacteriol 2002; 184:4912-9.
16. Ohman DE, Cryz SJ, Iglewski BH. Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol 1980; 142:836-42.
17. Yorgey P, Rahme LG, Tan MW, Ausubel FM. The roles of mucD and alginate in the virulence of Pseudomonas aeruginosa in plants, nematodes and mice. Mol Microbiol 2001; 41:1063-76.
18. Schwyn B, Neilands JB. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 1987; 160:47-56.
19. Heesemann J. Chromosomal-encoded siderophores are required for mouse virulence of enteropathogenic Yersinia species. FEMS Microbiol Lett 1987; 48:229-33.
20. Fleiszig SM, Arora SK, Van R, Ramphal R. FlhA, a component of the flagellum assembly apparatus of Pseudomonas aeruginosa, plays a role in internalization by corneal epithelial cells. Infect Immun 2001;69: 4931-7.
21. Barth AL, Pitt TL. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol 1995; 33:37-40.
22. Hornef MW, Roggenkamp A, Geiger AM, Hogardt M, Jacobi CA, Heesemann J. Triggering the ExoS regulon of Pseudomonas aeruginosa: a GFP-reporter analysis of exoenzyme (Exo) S, ExoT and ExoU synthesis. Microb Pathog 2000; 29:329-43.
23. Hogardt M, Roeder M, Schreff AM, Eberl L, Heesemann J. Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. Microbiology 2004; 150:843-51.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
25. Kresse AU, Dinesh SD, Larbig K, Romling U. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol Microbiol 2003; 47:145-58.
26. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I, Argarana CE. Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 2004; 150:1327-38.
27. Smith EE, Buckley DG, Wu Z, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006; 103:8487-92.
28. Romling U, Schmidt KD, Tummler B. Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats. J Mol Biol 1997; 271:386-404.
29. Bjedov I, Tenaillon O, Gerard B, et al. Stress-induced mutagenesis in bacteria. Science 2003; 300:1404-9.
30. Ferenci T. What is driving the acquisition of mutS and rpoS polymorphisms in Escherichia coli? Trends Microbiol 2003; 11:457-61.
31. van den BD, Chin AWT, Bloemberg GV, Lugtenberg BJ. Role of RpoS and MutS in phase variation of Pseudomonas sp. PCL1171. Microbiology 2005; 151:1403-8.
32. Lau GW, Hassett DJ, Ran H, Kong F. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 2004; 10:599-606.